The impact of cognitive interventions on cognitive symptoms in idiopathic Parkinson's disease: a systematic review

Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition
Marianne CoutureMartine Simard

Abstract

This systematic review addressed efficacy of cognitive stimulation (CS), cognitive training (CT), and cognitive rehabilitation (CR) to improve cognitive functions in Parkinson's disease (PD) with (PD-MCI) and without mild cognitive impairment (PD-H). Five databases were searched. Twelve CT, four CS, and a combination of CT with CR were found. PD-H benefited from CT or CS compared to active or passive controls in 42.1% of cognitive tests, and in 33.3% of psychological and functional measures. PD-MCI alone, compared with controls, only improved in 6.9% of cognitive measures after CT. PD-H and PD-MCI, alone or together, somehow improved information processing speed, attention, working memory, executive functions, and visual episodic memory. PD-MCI improved better than PD-H in global cognition and planning abilities. The outcomes suggest some efficacy of cognitive interventions in PD. However, small samples, lack of information regarding standardization of interventions, and poor methodological quality limit results validity and prevent firm conclusions.

References

Mar 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·A J HughesA J Lees
Jun 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·W R Gibb, A J Lees
Jan 29, 1999·Archives of Neurology·D J GelbS Gilman
Oct 27, 2001·Archives of Neurology·J Jankovic, A S Kapadia
Mar 14, 2003·Archives of Neurology·Dag AarslandPer Kragh-Sørensen
Aug 25, 2004·Journal of Internal Medicine·R C Petersen
Jun 13, 2006·Journal of the Neurological Sciences·Gebhard SammerDieter Vaitl
Mar 12, 2010·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Léonie JeanMartine Simard
Mar 29, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Anna Prats ParísAngels Rusiñol Bayés
May 7, 2011·Journal of Geriatric Psychiatry and Neurology·Jan MohlmanBianca Georgescu
Jun 11, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Irene LitvanDaniel Weintraub
Aug 31, 2011·International Journal of Alzheimer's Disease·Sarah Tardif, Martine Simard
Dec 29, 2011·Frontiers in Neurology·Cristina NombelaMaría Trinidad Herrero
Jan 26, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Irene LitvanMurat Emre
Feb 22, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·John V HindleElke Kalbe
Jun 7, 2013·The Cochrane Database of Systematic Reviews·Alex Bahar-FuchsBob Woods
Jul 23, 2013·Age and Ageing·Alison Jane YarnallDavid John Burn
Aug 13, 2013·Neurology Research International·Natalie C PalavraSimon J G Lewis
Feb 21, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Antonio CerasaAldo Quattrone
Jun 27, 2014·Journal of the International Neuropsychological Society : JINS·Alberto CostaGiovanni Augusto Carlesimo
Sep 23, 2014·Parkinsonism & Related Disorders·Annette PetrelliElke Kalbe
Apr 9, 2015·Alzheimer Disease and Associated Disorders·David K JohnsonJames E Galvin
Apr 9, 2015·Frontiers in Human Neuroscience·Francesco AngelucciAlberto Costa
Nov 1, 2015·Neurology·Isabella H K LeungAmit Lampit
Oct 1, 2016·Parkinson's Disease·Daniel Glizer, Penny A MacDonald
Jun 7, 2017·Neurorehabilitation and Neural Repair·Blake J LawrenceAndrea M Loftus

❮ Previous
Next ❯

Methods Mentioned

BETA
MDS

Software Mentioned

CogniPlus
REHACOP
RehaCom
Excel
NeuroVitalis
Google Scholar

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.